JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

CareDx Inc

Cerrado

SectorSanidad

21.51 3.51

Resumen

Variación precio

24h

Actual

Mínimo

21.39

Máximo

21.98

Métricas clave

By Trading Economics

Ingresos

-5.8M

-4.1M

Ventas

8.3M

108M

P/B

Media del Sector

14.645

67.147

BPA

0.12

Margen de beneficios

-3.79

Empleados

761

EBITDA

-5.7M

1.5M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+15.02% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

119M

1.1B

Apertura anterior

18

Cierre anterior

21.51

Noticias sobre sentimiento de mercado

By Acuity

40%

60%

112 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Neutral Evidence

CareDx Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

3 may 2026, 23:47 UTC

Ganancias

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 may 2026, 22:35 UTC

Ganancias

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 may 2026, 23:39 UTC

Charlas de Mercado

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 may 2026, 23:34 UTC

Charlas de Mercado

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 may 2026, 23:32 UTC

Ganancias

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 may 2026, 23:30 UTC

Charlas de Mercado

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 may 2026, 23:20 UTC

Charlas de Mercado

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 may 2026, 23:16 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 may 2026, 22:57 UTC

Adquisiciones, fusiones, absorciones

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 may 2026, 22:45 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

3 may 2026, 22:45 UTC

Charlas de Mercado

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 may 2026, 22:20 UTC

Ganancias

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 may 2026, 22:08 UTC

Ganancias

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 may 2026, 22:05 UTC

Ganancias

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 may 2026, 22:04 UTC

Ganancias

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 may 2026, 22:03 UTC

Ganancias

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 may 2026, 22:03 UTC

Ganancias

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 may 2026, 22:02 UTC

Ganancias

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 may 2026, 22:01 UTC

Ganancias

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 may 2026, 15:06 UTC

Ganancias

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Comparación entre iguales

Cambio de precio

CareDx Inc previsión

Precio Objetivo

By TipRanks

15.02% repunte

Estimación a 12 Meses

Media 24.73 USD  15.02%

Máximo 28 USD

Mínimo 21 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para CareDx Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

6 ratings

2

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

14.77 / 18.49Soporte y Resistencia

Corto Plazo

Neutral Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Weak Bearish Evidence

Sentimiento

By Acuity

112 / 347 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de CareDx Inc

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.
help-icon Live chat